Search Results - "Esquerre, Mariana Muñoz"
-
1
High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study
Published in PloS one (27-06-2013)“…A subclinical left ventricle diastolic dysfunction (LVDD) has been described in patients with chronic obstructive pulmonary disease (COPD). To evaluate the…”
Get full text
Journal Article -
2
Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease
Published in PloS one (05-04-2016)“…Chronic Obstructive Pulmonary Disease (COPD) is associated with subclinical systemic atherosclerosis and pulmonary vascular remodelling characterized by…”
Get full text
Journal Article -
3
Impact of the implementation of a telemedicine program on patients diagnosed with asthma
Published in BMC pulmonary medicine (13-01-2024)“…Asthma is one of the most common respiratory ailments worldwide. Despite broad understanding of the illness and of the available therapeutic options for it,…”
Get full text
Journal Article -
4
Is the purinergic pathway involved in the pathology of COPD? Decreased lung CD39 expression at initial stages of COPD
Published in Respiratory research (28-05-2018)“…Extracellular adenosine triphosphate (ATP) is up-regulated in the airways of patients with chronic obstructive pulmonary disease (COPD), resulting in increased…”
Get full text
Journal Article -
5
Vascular disease in COPD: Systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)
Published in PloS one (18-05-2017)“…The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Obstructive Pulmonary Disease (COPD) is not fully understood…”
Get full text
Journal Article -
6
Inflammatory markers and circulating extracellular matrix proteins in patients with chronic obstructive pulmonary disease and left ventricular diastolic dysfunction
Published in The clinical respiratory journal (01-11-2017)“…Left ventricular diastolic dysfunction (LVDD) is a frequent condition in chronic obstructive pulmonary disease (COPD). Tenascin-C (Tn-C) and matrix…”
Get more information
Journal Article -
7
Impact of comorbidities on the achievement of specific therapeutic goals in biologic‐treated asthma patients
Published in Allergy (Copenhagen) (01-08-2024)Get full text
Journal Article -
8
Comparative effectiveness of anti‐IL5 and anti‐IgE biologic classes in patients with severe asthma eligible for both
Published in Allergy (Copenhagen) (01-07-2023)“…Background Patients with severe asthma may present with characteristics representing overlapping phenotypes, making them eligible for more than one class of…”
Get full text
Journal Article -
9
Factors associated with suboptimal response to monoclonal antibodies in severe asthma
Published in Allergy (Copenhagen) (01-08-2023)Get full text
Journal Article -
10
Sudan red dye: a new agent causing type-2 occupational asthma
Published in Allergy, asthma, and clinical immunology (30-01-2020)“…Sudan red or 1-[(2-methoxyphenyl)azo]-2-naphthol is a low molecular weight azoic agent widely used in industry, particularly in the production of hair dyes…”
Get full text
Journal Article -
11
Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
Published in International journal of chronic obstructive pulmonary disease (01-01-2016)“…Exacerbations of COPD represent an important medical and health care problem. Certain susceptible patients suffer recurrent exacerbations and as a consequence…”
Get full text
Journal Article -
12
Imbalance in the Expression of Genes Associated with Purinergic Signalling in the Lung and Systemic Arteries of COPD Patients
Published in Scientific reports (26-02-2019)“…Growing evidence indicates that purinergic signalling is involved in the pathogenesis of chronic obstructive pulmonary disease (COPD) and in the vascular…”
Get full text
Journal Article -
13
Challenges for asthma units in response to COVID-19: a qualitative group dynamics analysis
Published in The Journal of asthma (03-06-2022)“…To develop a set of recommendations for the management of severe asthma during COVID-19 pandemic. Eleven pneumologists and allergologists who were staff…”
Get full text
Journal Article -
14
Roflumilast added to triple therapy in patients with severe COPD: A real life study
Published in Pulmonary pharmacology & therapeutics (01-02-2015)“…Abstract Background Roflumilast is used in severe chronic obstructive pulmonary disease (COPD) patients with frequent exacerbations. However, limited…”
Get full text
Journal Article -
15
The Response to Biologics is Better in Patients with Severe Asthma Than in Patients with Asthma-COPD Overlap Syndrome
Published in Journal of asthma and allergy (01-01-2022)“…Although biologics have demonstrated to be effective in T2-high asthma patients, there is little experience with these drugs in asthma-COPD overlap (ACO). The…”
Get full text
Journal Article -
16
Effectiveness of a Respiratory Day Hospital Program to Reduce Admissions for Exacerbation in Patients with Severe COPD: A Prospective, Multicenter Study
Published in Chronic obstructive pulmonary disease (04-05-2017)“…The respiratory Day Hospital (DH) is a care facility currently operating at various healthcare institutions. It monitors patients with severe chronic…”
Get more information
Journal Article -
17
Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients
Published in International journal of chronic obstructive pulmonary disease (01-01-2018)“…A higher risk of atherothrombotic cardiovascular events, which are platelet-driven processes, has been described during acute exacerbations of chronic…”
Get full text
Journal Article -
18
Gene and Protein Expression of Fibronectin and Tenascin-C in Lung Samples from COPD Patients
Published in Lung (01-06-2015)“…Purpose Fibronectin (Fn) and tenascin-C (TnC) are two extracellular matrix proteins associated with remodeling changes. Fn and TnC gene and protein expression…”
Get full text
Journal Article -
19
Vascular disease in COPD: systemic and pulmonary expression of PARC (Pulmonary and Activation-Regulated Chemokine)
Published in PloS one (18-05-2017)“…Introduction: The role of Pulmonary and Activation-Regulated Chemokine (PARC) in the physiopathology of Chronic Obstructive Pulmonary Disease (COPD) is not…”
Get full text
Journal Article -
20
Highlights del 55.° Congreso SEPAR
Published in Open respiratory archives (01-01-2023)“…Resumen: El 55.° Congreso SEPAR, celebrado en Pamplona del 2 al 4 de junio de 2022, volvió a ser, una vez más, la reunión científica de referencia para los…”
Get full text
Journal Article